MacroGenics | MGNX - Текущие обязательства





Текущие обязательства Изменить Дата
AbbVie USD 41.64B 458M 2026-06
Amgen USD 25.5B 547M 2026-06
AstraZeneca USD 31.55B 1.02B 2026-06
Biogen USD 3.92B 918.2M 2026-06
Bristol-Myers Squibb USD 18.66B 499M 2026-06
Daiichi Sankyo JPY 765.7B 119.32B 2026-06
Eli Lilly USD 47.74B 11.11B 2026-06
Genmab DKK 1.14B 38M 2026-06
Geron USD 70.33M 3.24M 2026-06
Gilead Sciences USD 11.02B 1.54B 2026-06
J&J USD 54.9B 2.82B 2026-06
Karyopharm Therapeutics USD 117.3M 25.24M 2026-03
MacroGenics USD 108.82M 12.88M 2026-06
Merck USD 27.73B 786M 2026-06
Pfizer USD 32.65B 1.7B 2026-06
Puma Biotechnology USD 82.73M 3.63M 2025-09
Regeneron Pharmaceuticals USD 5.53B 422.9M 2026-06
Roche Holding CHF 28.85B 846M 2026-06
Xencor USD 81.86M 8.41M 2026-06